Gemtuzumab treatment represents a significant development in the therapy of acute myeloid cancer, especially aggressive blood malignancy (AML). This novel conjugate joins a humanized protein directed to the receptor https://prbookmarkingwebsites.com/story28379575/gemtuzumab-ozogamicin-ozogamicin-a-full-review